Chenghong Yin

666 total citations
27 papers, 461 citations indexed

About

Chenghong Yin is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Hepatology. According to data from OpenAlex, Chenghong Yin has authored 27 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 8 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Chenghong Yin's work include Liver physiology and pathology (8 papers), Prenatal Screening and Diagnostics (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Chenghong Yin is often cited by papers focused on Liver physiology and pathology (8 papers), Prenatal Screening and Diagnostics (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Chenghong Yin collaborates with scholars based in China, United States and Germany. Chenghong Yin's co-authors include Ruixia Liu, Xiaoya Liu, Lijian Cui, Fei Hou, Yan Wen, Cheng Chi, Xiaoling Deng, Wei Zhong, YX Chen and Yong Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Food Research International.

In The Last Decade

Chenghong Yin

24 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenghong Yin China 11 150 130 120 95 71 27 461
Daniel Pineda‐Tenor Spain 12 134 0.9× 41 0.3× 184 1.5× 48 0.5× 10 0.1× 45 420
José María Vera-Cruz Mexico 10 250 1.7× 124 1.0× 282 2.4× 68 0.7× 4 0.1× 13 563
Xiaojun Li China 14 45 0.3× 224 1.7× 144 1.2× 68 0.7× 21 0.3× 43 734
Wafaa M. Ezzat Egypt 13 191 1.3× 159 1.2× 204 1.7× 36 0.4× 8 0.1× 43 526
Fotini Debonera United States 9 196 1.3× 246 1.9× 129 1.1× 176 1.9× 9 0.1× 18 579
Zhihong Wan China 16 221 1.5× 87 0.7× 213 1.8× 56 0.6× 26 0.4× 30 482
Mohammad Ali‐Hassanzadeh Iran 12 38 0.3× 107 0.8× 82 0.7× 40 0.4× 16 0.2× 34 419
Lin Zheng China 10 13 0.1× 73 0.6× 63 0.5× 67 0.7× 9 0.1× 23 302
Linda C. Rogers United States 8 47 0.3× 96 0.7× 53 0.4× 93 1.0× 102 1.4× 13 397

Countries citing papers authored by Chenghong Yin

Since Specialization
Citations

This map shows the geographic impact of Chenghong Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghong Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghong Yin more than expected).

Fields of papers citing papers by Chenghong Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghong Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghong Yin. The network helps show where Chenghong Yin may publish in the future.

Co-authorship network of co-authors of Chenghong Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghong Yin. A scholar is included among the top collaborators of Chenghong Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghong Yin. Chenghong Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Weigang, et al.. (2025). A retrospective analysis of 38,652 amniotic fluid karyotype. Frontiers in Genetics. 16. 1655290–1655290.
2.
Yin, Chenghong, et al.. (2025). Insight into the flavor characteristics and antioxidant activity in Xiaoqinggan black tea. Food Research International. 221(Pt 2). 117227–117227. 1 indexed citations
3.
Chen, Caiyun, Xiaochong Shi, S N Yin, et al.. (2024). Application of the online teaching model based on BOPPPS virtual simulation platform in preventive medicine undergraduate experiment. BMC Medical Education. 24(1). 1255–1255. 5 indexed citations
5.
Chi, Cheng, et al.. (2023). SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis. SHILAP Revista de lepidopterología. 23(6). 1014–1025. 3 indexed citations
6.
Li, Zhengpeng, et al.. (2022). The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing. Current Research in Translational Medicine. 71(1). 103354–103354. 9 indexed citations
7.
Liu, Jing, et al.. (2021). Congenital bilateral cryptorchidism in an infant conceived after maternal breast cancer treatment: A case report. World Journal of Clinical Cases. 9(12). 2923–2929.
8.
Chen, Min, Chao Chen, Junwei Sun, et al.. (2020). Noninvasive prenatal diagnosis for Duchenne muscular dystrophy based on the direct haplotype phasing. Prenatal Diagnosis. 40(8). 918–924. 7 indexed citations
9.
Li, Shanshan, et al.. (2020). Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma. Molecular Cytogenetics. 13(1). 10–10. 33 indexed citations
10.
Pei, Yan, Chenghong Yin, Yuxin Jiang, et al.. (2019). Subchromosomal anomalies in small for gestational-age fetuses and newborns. Archives of Gynecology and Obstetrics. 300(3). 633–639. 7 indexed citations
11.
Shan, Dan, Hao Wang, Yue Niu, et al.. (2019). The Urinary Peptidome as a Noninvasive Biomarker Development Strategy for Prenatal Screening of Down's Syndrome. OMICS A Journal of Integrative Biology. 23(9). 439–447. 10 indexed citations
12.
Chi, Cheng, Xiaoya Liu, Fei Hou, et al.. (2018). Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats. BMC Complementary and Alternative Medicine. 18(1). 52–52. 12 indexed citations
13.
Ruan, Xiangyan, Juan Du, M. Korell, et al.. (2018). Case report of the first successful cryopreserved ovarian tissue retransplantation in China. Climacteric. 21(6). 613–616. 23 indexed citations
14.
Hou, Fei, Ruixia Liu, Xiaoya Liu, et al.. (2017). Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis. International Journal of Molecular Medicine. 41(3). 1315–1322. 2 indexed citations
15.
Liu, Xiaoya, Ruixia Liu, Fei Hou, et al.. (2016). Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro. Molecular Medicine Reports. 14(4). 3669–3675. 70 indexed citations
16.
Hou, Fei, Ruixia Liu, Xiaoya Liu, et al.. (2016). Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7/Smad signaling in the bile duct ligation model rat. Molecular Medicine Reports. 13(5). 4335–4342. 13 indexed citations
18.
Wang, Jing, et al.. (2010). An outbreak of Angiostrongyliasis cantonensis in Beijing. Journal of Parasitology. 96(2). 377–381. 35 indexed citations
19.
Yin, Chenghong, Ying Liu, Jianghong Chen, et al.. (2005). Clinical study on high-resolution CT and pulmonary function in severe acute respiratory syndrome patients during recovery phase.. PubMed. 118(6). 512–5. 1 indexed citations
20.
Yin, Chenghong. (2000). The inactivation effect on lipoperoxidation in liver tissue of mice of inhibition by the drug serum Dang Gui Bu Xue decoction.. Zhongguo zhongyiyao xinxi zazhi. 7(2). 23–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026